Target intelligence / Profile preview

Fatty acyl-CoA reductase 2 (FAR2)

Target
FAR2
Molecular classification
Enzyme, Short chain dehydrogenase/reductase (SDR) family
01

Overview

Fatty acyl-CoA reductase 2 (FAR2) is an enzyme that catalyzes the reduction of saturated (but not unsaturated) C16 or C18 fatty acyl-CoA substrates to their corresponding fatty alcohols[1][2][4]. This process is critical for fatty alcohol biosynthesis and lipid metabolism, with implications for cellular membrane composition and signaling. Genetic or functional changes in FAR2 have been implicated in the development of mesangial matrix expansion and chronic kidney disease[3][5]. FAR2 belongs to the short chain dehydrogenase/reductase (SDR) family and is known by several alternative names and symbols. No direct approved drugs or safety concerns have been commonly described for FAR2 based on currently available biomedical data.

Other names
Male sterility domain-containing protein 1MLSTD1FLJ10462SDR10E2HEL-S-81epididymis secretory protein Li 81short chain dehydrogenase/reductase family 10E member 2
02

Biological functions

Fatty alcohol biosynthesisLipid metabolism
03

Disease associations

Chronic kidney disease (associated via mesangial matrix expansion)Other (potential metabolic and reproductive roles)

Beyond the preview

Go deeper on Fatty acyl-CoA reductase 2 (FAR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fatty acyl-CoA reductase 2 (FAR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call